Dashboard
Manage Tickers

PRTC PureTech Health plc

Nasdaq puretechhealth.com


$ 17.86 $ -0.02 (-0.14 %)    

Monday, 03-Nov-2025 09:39:34 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 622.90 $ 0.00 (0 %)
DIA $ 469.30 $ 0.00 (0 %)
SPY $ 675.68 $ 0.00 (0 %)
TLT $ 89.93 $ 0.00 (0 %)
GLD $ 367.45 $ 0.00 (0 %)
$ 17.75
$ 17.69
$ 17.00 x 30
$ 19.07 x 120
-- - --
$ 13.30 - $ 24.99
931
na
8.04B
$ 0.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

puretech-health-to-share-new-data-from-ongoing-phase-1b-clinical-trial-evaluating-lyt-200-anti-galectin-9-monoclonal-antibody-in-rraml-at-ash-2025
PureTech Health To Share New Data From Ong...
11/03/2025 14:18:33

LYT-200 continues to demonstrate strong evidence of clinical activity, survival benefit and a highly favorable safety profile i...

puretech-highlights-deupirfenidones-ability-to-stabilize-lung-function-while-maintaining-strong-tolerability-in-older-adults-with-idiopathic-pulmonary-fibrosis-at-chest-2025-annual-meeting
PureTech Highlights Deupirfenidone's Abili...
10/22/2025 07:18:40

puretech-presents-phase-2b-open-label-extension-data-showing-deupirfenidone-stabilizes-lung-function-in-ipf-with-favorable-tolerability
PureTech Presents Phase 2b Open-Label Exte...
09/29/2025 07:20:25

Patients who switched from placebo or pirfenidone to deupirfenidone in the open-label extension study achieved stabilization of...

coreweave-barrick-mining-fedex-and-other-big-stocks-moving-higher-on-friday
CoreWeave, Barrick Mining, FedEx And Other...
09/19/2025 14:31:28

puretech-founded-entity-seaport-therapeutics-doses-first-participant-in-phase-1-study-of-glyphago-spt-320-oral-prodrug-of-agomelatine-for-generalized-anxiety-disorder
Puretech Founded Entity Seaport Therapeuti...
09/11/2025 11:11:41

Core News & Articles
Earnings Scheduled For August 28, 2025
08/28/2025 08:32:14

puretech-health-h1-eps-019-down-from-015-yoy-sales-185m-up-from-28800k-yoy
PureTech Health H1 EPS $(0.19) Down From $...
08/28/2025 06:37:48

PureTech Health (NASDAQ:PRTC) reported quarterly losses of $(0.19) per share. This is a 26.67 percent decrease over losses of $...

puretech-health-showcases-phase-2b-data-at-ipf-summit-launches-celea-therapeutics-to-advance-deupirfenidone-toward-phase-3
PureTech Health Showcases Phase 2b Data At...
08/21/2025 11:06:54

puretech-healths-founded-entity-vedanta-biosciences-says-its-candidate-ve202-did-not-meet-primary-endpoint-in-phase-2-collective202-study-for-treatment-of-uc-patients
PureTech Health's Founded Entity, Vedanta ...
08/13/2025 16:49:43

VE202 was well tolerated, with no reports of treatment-related serious adverse eventsAdditional analyses from COLLECTiVE202 to ...

puretech-health-launches-celea-therapeutics-to-transform-treatment-of-respiratory-diseases
Puretech Health Launches Celea Therapeutic...
08/12/2025 11:15:17

Former Teva North America CEO Sven Dethlefs, PhD, to lead CeleaPureTech Health plc (NASDAQ:PRTC, LSE: PRTC))) ("PureTech...

puretech-founded-entity-seaport-therapeutics-doses-first-patient-in-phase-2b-buoy-1-study-of-glyphallo-for-major-depressive-disorder
PureTech Founded Entity, Seaport Therapeut...
07/17/2025 11:08:04

puretech-ceo-bharatt-chowrira-steps-down-after-eight-years-board-appoints-robert-lyne-as-interim-chief-executive-officer
PureTech CEO Bharatt Chowrira Steps Down A...
07/16/2025 06:32:06

puretech-health-board-chair-raju-kucherlapati-steps-down-appoints-sharon-barber-lui-as-interim-chair
PureTech Health Board Chair Raju Kucherlap...
07/08/2025 16:48:34

why-this-biotech-stock-just-doubled-in-a-single-day
Why This Biotech Stock Just Doubled In A S...
06/26/2025 16:12:29

Vor Biopharma shares surge 43% after licensing deal, $175M raise, and CEO transition.

puretech-presents-phase-2b-data-for-deupirfenidone-at-ats-2025-showing-statistically-significant-slowing-of-ipf-progression-with-durable-effect-over-52-weeks-favorable-safety-profile-and-plans-for-fda-meeting-and-phase-3-trial-launch-by-end-of-2025
PureTech Presents Phase 2b Data For Deupir...
05/20/2025 21:16:59

Deupirfenidone 825 mg TID slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF) to the range expected...

puretech-announces-publication-of-new-research-highlighting-untold-experiences-of-people-living-with-idiopathic-pulmonary-fibrosis
PureTech Announces Publication Of New Rese...
05/09/2025 11:03:33

puretech-says-it-will-present-results-from-phase-2b-elevate-ipf-trial-of-deupirfenidone-lyt-100-at-american-thoracic-society-international-conference-regulatory-and-strategic-planning-underway-to-advance-deupirfenidone-into-phase-3-development
PureTech Says It Will Present Results From...
05/01/2025 11:44:14

Core News & Articles
Earnings Scheduled For April 30, 2025
04/30/2025 08:32:41

puretech-health-fy-eps-021-up-from-024-yoy-sales-483m-up-from-333m-yoy
PureTech Health FY EPS $0.21 Up From $(0.2...
04/30/2025 06:50:03

PureTech Health (NASDAQ:PRTC) reported quarterly earnings of $0.21 per share. This is a 187.5 percent increase over losses of $...

greenbrier-rpm-international-cvrx-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Greenbrier, RPM International, CVRx And Ot...
04/08/2025 12:35:36

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION